Growth Continues at KeriCure, Inc. with Funding Through the Institute for the Commercialization of Public Research

Top Quote A startup company founded by USF PhD professors, KeriCure has received a round of funding to get its innovative new wound care products on shelves and in doctors' offices around the country. End Quote
  • (1888PressRelease) December 12, 2012 - Tampa, FLA. - KeriCureTM Inc. (KeriCure) announced today that it has finalized a funding agreement with the Institute for the Commercialization of Public Research, a not for profit organization that works with Florida's research universities and institutions to support new company and job growth. KeriCure is engaged in development and commercialization of advanced platform polymer technology, based on research conducted at the University of South Florida. The goal of the Institute program is to bridge company funding gaps, enabling them to reach critical milestones and attract additional private investment capital.

    KeriCure's wound care technology delivers a water-based solution, ultimately providing hydration, cooling, and natural debridement to the wound bed while maintaining a moist wound environment. Breathable and highly elastic, KeriCure wound care technology provides a solid polymer film that forms over damaged tissue. Application immediately calms nerve endings, providing a soothing effect, and blocks bacterial colonization in the wound. By offering a variety of topical products, KeriCure is designed to promote healing, prevent infection, and reduce associated costs for care.

    "Funds made available through the Seed Capital Accelerator Program, combined with private matching funds will facilitate several strategic initiatives for KeriCure including FDA clearance and launch of our liquid bandage product line with an initial focus in the natural products market through a multi-pronged deployment process," commented Kerriann Greenhalgh, Founder and CEO. "

    Just last year, the Institute has committed nearly 65% of funding available to promising companies like KeriCure, and we look forward to following their development and growth," said Jamie Grooms, Institute President and Chief Executive Officer. "This program is a critical component of Florida's innovation and economic development strategy, helping companies develop and launch their products, grow and succeed."

    About KeriCure, Inc.
    Kericure, Inc. is a Tampa based company that provides wound care products to patients, military and everyday consumers. Exclusively licensed by the University of South Florida, KeriCure was formed to commercialize an advanced platform polymer technology, KeriCure Quick Seal Liquid Bandage. The water-based, sting-free products prevent infection, reduce pain and promote healing.

    About the Institute
    Founded in 2007 as a non-profit organization, the Institute is Florida's One-Stop-Shop for investors and entrepreneurs who seek to identify new opportunities based on technologies developed through publicly-funded research. The Institute delivers programs that facilitate new venture and job creation through commercially-viable technologies in major industries that are driving the global economy. The Institute also administers the Florida Research Commercialization Matching Grant Program launched in 2010, and the Seed Capital Accelerator Program launched in 2011.

  • FB Icon Twitter Icon In-Icon
Contact Information